Navigation Links
Seattle based non-profit, The Institute for Venture Science (IVS) today announced receipt of a significant operating grant from 1Plus12 Corporation.
Date:4/26/2016

Seattle based non-profit, The Institute for Venture Science (IVS) today announced receipt of a significant operating grant from 1Plus12 Corporation. The grant will be used to further the scientific research goals of the Institute and to commence pre-proposal activities as outlined on the organization's website http://www.ivsci.org

In accounting the grant to the IVS, Mr. Glenn Estrabillo of Toronto Canada, the CEO of 1Plus12 Corporation, explained that he was impressed with the goals and objectives of the IVS and that he hoped to assist in implementing the yet to be identified research projects supported by the IVS. “Not only am I pleased to have arranged this contribution, I am also pleased to have agreed to serve on the Board of Directors of the IVS”. In addition to Mr. Estrabillo’s service, Mr. Sai Mohammed and Mr. James Destephanis of the 1Plus12 Corporation have agreed to participate as members of the IVS Advisory Panel.

In regards to the announcement of Mr. Estrabillo’s participation in the organization, Dr. James Ryder, Chairman of the Institute for Venture Science commented, “it is a delight to have a new member of the board closely connected to the investment world and with a focus on helping others to empower themselves”.

Dr. Ryder also announced the selection of Dr. Beverly Rubik as an additional member of the Board of Directors. In announcing Dr. Rubik, Dr. Ryder said, “we are pleased to have a board member with the experience of having been involved in the issues of fostering a broadening in scientific thought”. Dr. Rubik commented, “Scientific research that challenges the mainstream is extremely rare because it is so difficult to find the necessary support. There is a serious need for novel approaches in science, and IVS takes a leadership role in facilitating this at its best.”

The IVS held its launch symposium in September 2015 with noted speakers and attendees, including several Nobel laureates. The organization hopes to help fund promising ideas that challenge conventional thinking through a unique multi-locational approach to such issues. The IVS has called for “pre-proposals” to identify areas of exploration.

The organization continues its fund drive to be able to fund anticipated worthwhile investigations.

Further information can obtained by visiting http://www.IVSCI.org or by email harold(at)ivsci(dot)org.

Read the full story at http://www.prweb.com/releases/2016/04/prweb13369533.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. Todays Technical View: Elan Corp., Amarin, Seattle Genetics, and Cubist Pharma
2. Affordable Scrum Training in Seattle, WA – 8 PDUs by Conscires Agile Practices
3. Seattle Childrens shares results of national study tracking cognitive development of children with craniosynostosis
4. Seattle Childrens Opens Patient Enrollment for First Tumor Paint Clinical Trial for Children With Brain Cancer
5. Seattle Biotech Firm, SpringStar, Steps-Up Fight Against Zika and Dengue Fever
6. BioGenex Will Introduce Fully Integrated miRNA-ISH System for Tumor Diagnosis and Clinical Research at the USCAP Annual Meeting in Seattle, WA
7. Nabsys Secures $20 Million Series D Financing to Support Launch of Semiconductor-Based Single-Molecule Platform for Genomic Analysis
8. Connecticut-Based Contract Staffing Recruiters Adds More Career Boards and Staff
9. SRI International Licenses Bed Bug Detection Technology to Redcoat, a Virginia-Based Start-Up Company
10. Leading Chemical Manufacturer Expands Biobased Offering through Unique Distribution of Proven Green Spill Absorbent
11. Report Says Mold Stirs Herndon High School, My Cleaning Products Asserts Organic-Based and No-Scrubbing Mold Remediation Products Are the Answers to the Mold Problem
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2018)... ... 24, 2018 , ... ExoCoBio Inc., based in South Korea, ... and inhibits a variety of inflammatory targets in the journal of Stem Cell ... having severe atopic dermatitis were significantly improved after administration of stem cell-derived exosomes ...
(Date:8/21/2018)... ... August 21, 2018 , ... ... commercialization, has just released a new paper discussing systems engineering for non-profit ... Kossmann, ESEP at the 28th Annual INCOSE International Symposium, the paper describes ...
(Date:8/17/2018)... ... 16, 2018 , ... KCAS Bioanalytical and Biomarker Services, a ... their team. Dr. Dawn Dufield, Ph.D., joins KCAS as Director of BioPharma. , ... that will specialize in developing quantitative LC-MS/MS assays for biopharma molecules. Dr. Dufield ...
(Date:8/14/2018)... ... 13, 2018 , ... Labconco Corporation manufactures laboratory equipment, specializing ... addition, Labconco produces other lab equipment, such as glassware washers and freeze dryers. ... consistency in design and manufacturing. , Through this webinar, which is sponsored ...
Breaking Biology Technology:
(Date:8/21/2018)... MADISON, Wis. (PRWEB) , ... August 21, 2018 ... ... of high throughput screening (HTS) solutions, Bellbrook Labs is dedicated to offering customers ... regarding biochemical assays, visitors will find a seamless transition between products, with relevant ...
(Date:8/17/2018)... ... 16, 2018 , ... With increasing safety requirements, and time and financial pressure, ... multiple challenges. To be successful in such a competitive environment, it is more important ... multiple tasks needed to develop a new drug or to execute fundamental research. ...
(Date:8/17/2018)... (PRWEB) , ... August 16, 2018 , ... ... the world’s first private cord blood bank to separate and store stem cells ... Law Center, and Brian Sheehy, M.D. M.A. C.F.A., Founder and Managing Partner IsZo ...
Breaking Biology News(10 mins):